WHY IT MATTERS: Patients using medical cannabis should know that a formal diagnosis or physician recommendation does not eliminate the risk of developing Cannabis Use Disorder, and open communication with your prescribing doctor about frequency and dosage is essential for long-term safety. CLINICAL OVERVIEW: Cannabis Use Disorder is a clinically recognized condition characterized by continued use despite negative consequences, with estimated prevalence rates ranging from roughly 9% of all users to as high as 33% among daily users. The medicalization of cannabis has created a complex dynamic where legitimate therapeutic access may, in some patients, lower the perceived risk of the substance and contribute to problematic use patterns.
Study: Teen Cannabis Use Linked to Double Psychosis Risk – Ground News
New research links adolescent cannabis use to a significantly higher risk of psychosis. Here’s what you need to know: Teen cannabis use was associated with roughly 2x the risk of developing psychotic disorders Genetic predisposition and frequency of use likely play major roles ️ The adolescent brain is still developing well into the mid-20s Medical cannabis programs screen for psychiatric risk factors for exactly this reason This is not about fear — it’s about informed, age-appropriate decisions Cannabis can be powerful medicine for adults under proper guidance. But for teens, the risk-benefit equation is very different. Talk to your kids. Talk to your doctor. Knowledge is harm reduction. New study links teen cannabis use to doubled psychosis risk. This is why age, dose, and clinical oversight matter.